Background: Our aim was to study the impact of lifelong HIV disease history on the
Highly active anti-retroviral therapy (HAART) has transformed HIV disease into a stable chronic condition. Infected children born at the beginning of the epidemic are now reaching adulthood [1] . The many specific features of pediatric HIV disease preclude an extrapolation from data gathered in adults. In the absence of treatment, infected children have a high level of viral replication that persists for several years, and their immune system develops in the presence of an immunosuppressive virus [2] [3] . This heavy exposure to deleterious viral replication is counterbalanced by high thymic activity that provides a better replenishment of CD4 T-lymphocytes than in infected adults [4] [5] . The unique characteristics of perinatal infection described in children may be altered by long-term exposure to viral replication, various antiretroviral (ARV) treatments and pubertal development. Improvements in our knowledge of the virological and immunological status of these patients, who are now approaching adulthood is required, as these characteristics are likely to affect future clinical progression.
In the French national perinatal cohort (ANRS-CO-10), 60% of the children born before 1994 and included at birth are still alive and regularly followed-up [6] . The first generation of HIV-1-infected children did not benefit from either the prophylaxis of vertical transmission or from early access to HAART. Many received nucleoside inhibitors of reverse transcriptase (NRTI) monotherapy as their initial treatment. In 2007, we set up the ANRS-EP38-IMMIP Study to focus on HIV-1 infected youths over the age of 15 years, who had been infected during the perinatal period. Through this study, we aimed to improve our knowledge of virological and immune status of these patients, by assessing biological parameters not evaluated in routine clinical practice and identifying correlations between these parameters and life-long HIV disease parameters.
Cell-associated HIV DNA load reflects the viral reservoir, whereas plasma HIV RNA load quantifies active viral replication [7] . Independently of HIV RNA load and CD4 cell counts, blood HIV DNA load is predictive of disease progression [8] [9] . In the absence of quantifiable viral replication, it is the only virological marker available and is predictive of residual replication and immune reconstitution in treated adults [10] [11] [12] [13] . In children, HIV DNA load is associated with clinical status, plasma viral load, CD4 cell counts, immune activation and HIV-specific immune responses [14] [15] [16] [17] . In children initiating HAART, a higher baseline HIV DNA level is associated with a longer time lag to undetectable HIV RNA levels and with virological failure [18] [19] . The results of studies of immune restoration under HAART differ considerably between pediatric and adult patients: HIV DNA levels have been associated with a limited increase in the number of naive CD4 lymphocytes in adults, but with higher thymic output in children [12-13, 18, 20] . We studied HIV DNA load and its relationship to lifetime HIV disease history, 15 years or more after perinatal infection.
Patients and methods

Study design
Between February 2007 and February 2009, 93 HIV-1-infected patients followed up at 10 clinical sites within the Paris area were enrolled in the ANRS-EP38-IMMIP Study. The inclusion criteria were (1) HIV-1 infection through the vertical route, (2) being over the age of 15 years, (3) absence of change in therapeutic status during the previous six months, (4) initiation into care before 1996, to ensure that all patients had similar access to HAART. This study was approved by the local ethic committees. Patients and their legal guardians signed an informed consent form. All but one of the patients were born in France. Sixty-eight patients were included at birth in the ANRS-CO-10 cohort [6] . Their current HAART status, HIV RNA load and CD4 cell counts were not significantly different from those of the other 25 perinatally infected patients. 
Results
Characteristics of patients
Current status
The 93 patients included in the ANRS-EP38-IMMIP Study were born between January 1983 and February 1994, and were between 15 and 24 years of age at the time of the study. Their current and past characteristics are presented in Since birth/start of follow-up, CD4 cell percentage had been below 25% at least once in all but one of the patients and below 15% at least once in 80% of the patients. Median times for which CD4 cell percentage were below 25% and 15% were 7.8 (IQR: 4.6-11.9) years and 1.9 (IQR: 0.5-4.1) years, respectively. Median zenith value of plasma viral load was 5.2 (IQR: 4.9-5.5) log10 HIV RNA copies/ml. Median cumulative period for which HIV RNA was below 500 copies/ml was 5.6 (IQR: 2.8-7.6) years. The most recent period for which HIV RNA was continuously below 500 copies/ml was much shorter (median (IQR): 1.6 (0-4.8) years).
Relations between current HIV DNA load and HIV disease history Table 2 ). The positive correlation between HIV DNA load and cumulative viremia was slightly stronger for the last five years period than for the last 10 years (r=0.524, P<0.0001 and r=0.474, P<0.0001) and for the twoand three-years periods (data not shown). Stratified analysis confirmed that virological history was associated with current HIV DNA load ( Table 2 ). Regardless of current HAART or HIV RNA status, HIV DNA load was correlated (or there was a trend toward correlation) with the length of time for which HIV RNA load was below 500 copies and cumulative viremia. HIV DNA load was not associated with age, CD4 cell percentage, HIV RNA load at HAART initiation, numbers of HAART interruptions, HIV RNA zenith levels, CD4 percentage nadir levels, or the duration of severe immunosuppression (Table 2) .
Multivariate analysis
As there was a significant interaction between the detection of HIV RNA and the CD4 cell count, we performed separate multivariate analysis in patients with detectable viral load and in those in whom HIV RNA was undetectable ( . In our study population, 64% of the patients interrupted HAART at least once, and the median time for which HIV RNA was below 500 copies/ml before this study was 1.6 years. Thus, taking into account the long duration of HIV infection and complex HAART history of these perinatally infected youths, their HIV DNA load was similar to that expected for adult patients.
Our results suggest that once the viral replication is suppressed, the previous viral history is the major factor associated with current cell-associated HIV DNA load. In early reports, HIV DNA levels were shown to decline over a limited period, ranging from nine This study shows that perinatally infected patients with regular care can achieve a good virological/immunological status, even after reaching advanced disease stages and being heavily ARV-treated for more than a decade. In successfully treated patients, viral replication history is a major determinant of cell-associated HIV DNA load. Most of the patients in this study began HAART during childhood and had reached adolescence or adulthood at the time of the study. Their HIV DNA loads were similar to those reported in adults with a similar disease history. However, their CD4 cell counts appeared to be slightly higher than those of adults with long-term HIV infection [26, [40] [41] . Furthermore, we report the absence of a correlation between HIV DNA load and CD4 cell counts when viral replication is suppressed, suggesting that the interactions between HIV replication and the immune system are specific in pediatric infection. Overall, our work shows that infection during the perinatal period has a long-term impact on the immune and virological status of HIV infection resulting in differences with respect to patients infected during adulthood.
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